Open roles at Newlimit
Latest Newlimit Signals
What they do
Newlimit, a San Francisco-based developer of cell reprogramming and epigenetic longevity medicines, raised $435 million in Series C funding led by Founders Fund, with participation from Thrive Capital and Eli Lilly Ventures. The funds will be used to advance age-reprogramming therapies and transition its lead liver-cell program into human clinical studies.
Why it matters
Newlimit has developed a prototype medicine that reverses cellular age in old human liver cells, leveraging cutting-edge cell reprogramming techniques. This innovative approach aims to initiate human trials by late 2027, potentially transforming the landscape of age-related therapies.
Traction
The company is in the advanced stages of developing its lead liver-cell program, which is set to enter human clinical trials. This positions Newlimit at the forefront of a burgeoning sector focused on longevity and cellular health, targeting a market that is increasingly prioritizing age-reversal solutions.
Where the market is going
Newlimit is challenging traditional pharmaceutical approaches to aging, which often focus on symptom management rather than underlying cellular mechanisms. By targeting cellular reprogramming, Newlimit is betting on a paradigm shift in how we understand and treat age-related diseases, positioning itself against established players in the longevity space.
Why Newlimit is hiring
Newlimit closed a $435M funding round in June 2026, with investors including Founders Fund, Thrive Capital and Eli Lilly Ventures. It currently has 15 open roles, 7 of them posted in the last 30 days, with hiring concentrated in South San Francisco.
Teams hiring
Where Newlimit hires
Similar Health companies hiring
Newlimit jobs: common questions
Is Newlimit hiring?
Yes. Newlimit has 15 open roles on SuperAIJobs right now, including 7 posted in the last 30 days. The list is refreshed daily from Newlimit’s own careers site.
Where are Newlimit jobs located?
Most open roles at Newlimit are in South San Francisco.
Does Newlimit hire remotely?
None of Newlimit’s current roles are listed as remote, so expect to work from one of its offices.
How much has Newlimit raised?
The latest round we track is a $435M funding round in June 2026. Investors include Founders Fund, Thrive Capital and Eli Lilly Ventures. See the full deal history on MapCo.
What does Newlimit do?
Newlimit has developed a prototype medicine that reverses cellular age in old human liver cells, leveraging cutting-edge cell reprogramming techniques.
How do I apply for a job at Newlimit?
Every role on this page links straight to Newlimit’s own application page, so you apply directly — SuperAIJobs never sits in between.